Roche Diagnostics Corporation of Indianapolis is the latest healthcare organization to partner with Marian University to build the new College of Osteopathic Medicine. The company has invested $75,000 to sponsor one of the simulation laboratories located in the Michael A. Evans Center for Health Sciences. The laboratory will be named the Roche Diagnostics Simulation Lab.
“Our focus at Roche is helping patients live longer, healthier lives through research and the development of personalized healthcare solutions, so we share several common goals with the new medical school,” said Jack Phillips, president and CEO of Roche Diagnostics’ North American operations, which are headquartered in Indianapolis. “We’re honored to help support this new venture and believe it will make a significant contribution to improving the health and quality of life of patients in Indiana and beyond,” Phillips added.
Building a new medical school for Indiana is an important project that will directly address the shortage of physicians in our state—an issue that has both economic and social ramifications. Indiana is already facing a shortage of doctors, and as the population ages, by 2020 will be short 5,000 physicians, 2,000 of which are primary care physicians “Directly addressing this need for more doctors will improve healthcare in Indiana. We appreciate Roche’s commitment to patient quality of life and its investment in the simulation lab and our new medical school,” said Dr. Paul Evans, founding dean of the College of Osteopathic Medicine.
The simulation labs are an important part of a medical students’ training. Simulation labs provide opportunities for students to practice procedures and gain skills and confidence while receiving immediate feedback. The lifelike models are programmed to emulate common medical conditions; students practice making split-second decisions that lead to life-saving best practices later on. The Michael A. Evans Center for Health Sciences, which will house the new medical school and the School of Nursing, is a $47 million construction project scheduled to open in the summer of 2013. Both medical and nursing students will train together in the building and share the simulation lab space. The building is part of a larger health and life sciences initiative on campus with financial needs totaling $160 million. For more information, visit the web site at www.marian.edu/medicalschool.
About Roche Diagnostics Corporation
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare, with combined strengths in pharmaceuticals and diagnostics, and has about 80,000 employees worldwide. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics and tissue-based cancer diagnostics and is a pioneer in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. Roche Diagnostics’ North American headquarters, located in Indianapolis, has about 4,200 employees and is home to U.S. research and development, laboratory, manufacturing, distribution, information technology and administrative operations. For more information: www.roche-diagnostics.us or www.roche.com.
About Marian University
Marian University is the only Catholic liberal arts university in central Indiana. It is a private, co-educational school offering classes to both traditional and non-traditional students. Located two miles northwest of downtown Indianapolis, it is dedicated to excellent teaching and learning in the Franciscan and liberal arts traditions. It is one of Indiana’s 31 independent colleges, and one of 244 Catholic colleges and universities in the United States. On July 1, 2009, Marian College became Marian University. On January 15, 2010, Marian University announced it would develop the first college of osteopathic medicine in the state of Indiana.